Monday, 29 October 2018

Amblyopia Market Share, Opportunities, Segmentation and Forecast to 2023

Amblyopia is an eye disorder which leads to decreased vision in one or both the eyes due to suppressed input from the brain. The most common cause of amblyopia is a refractive error in one or both eyes, or it might even occur due to muscle imbalance. The other cause of amblyopia is if the infant is born with a cataract, which causes cloudy images. There are four types of amblyopia, namely, Strabismus Amblyopia, Refractive Amblyopia, Deprivation Amblyopia, and Reverse Amblyopia. The global prevalence rate of Amblyopia is 2 to 3% of the infant population. Amblyopia market is driven by growing incidence of ophthalmological disorders such as cataracts, macular degeneration, glaucoma, and refractive errors. According to reports published by the United Kingdom Statistics Authority, in 2015, around 15,900 people were registered as visually impaired. Moreover, according to the Journal of Ophthalmology, as of 2014 there were around 28 million visually impaired people in the European region. With the increasing prevalence, there is increasing in the advancement of treatment and hence influencing the growth of the market. 
Global amblyopia market is expected to grow at a CAGR of 3.80% during the forecast period 2017-2023.
Segmentation                      
The global amblyopia market is segmented on the basis of type, diagnosis, treatment, and end-user.
On the basis the type, it is segmented into strabismus amblyopia, refractive amblyopia, deprivation amblyopia, reverse amblyopia, and other.
On the basis of the diagnosis, it is segmented into visual acuity tests, photo screening, Bruckner test and others.
On the basis of the treatment, it is segmented into eye patches, atropine drops, glasses, video game and others.
On the basis of the end-user, it is segmented into hospitals & pharmacies, ophthalmic clinics, and others.
Key Players                                                                                                         
Some of the key players in this market are Amblyoptica (Holding) Pty Ltd, Amblyotech, Inc, Good-Lite Co, Vivid Vision, Inc., Cooper Vision, Johnson & Johnson, Novartis AG., Carl Zeiss AG, HOYA Corporation, Krafty Eye Patches¸ Fresnel Prism and Lens Co., Hilco Vision, McKesson Corporation, and others.
Regional Analysis
The global amblyopia market, on the basis of region, is divided into the Americas, Europe, Asia Pacific and the Middle East & Africa. The Americas accounted for the largest market share of 37.9% in 2016 for global amblyopia market. This large share is majorly attributed due to the increasing prevalence of ophthalmological disorders, the presence of major manufacturers, increasing technological advancement and high healthcare expenditure. Europe accounts for the second largest market share, whereas Asia Pacific is expected to grow at the fastest rate with 4.35% CAGR for the forecast period. With lots of opportunity and continuously growing economies, the presence of huge patient population, rapid development in technology and presence of a huge opportunity for the development the region is expected to be the fastest growing region. The Middle East & Africa is growing at a slow pace, and the low income accounted for the least market share in 2016 but is expected to grow in the coming future.
Key Findings                                                                                                              
  • The global amblyopia market was USD 4327.0 million in 2016
  • Strabismus amblyopia is the largest segment, by type which is projected to grow at a CAGR of 3.47% during the forecast period from 2017-2023
  • Eye patches is the largest segment, by treatment for the global amblyopia and expected to grow at a rate of CAGR 3.93% during the forecast period
  • Currently, the Americas accounted for the largest market share in the global scenario, whereas Asia Pacific is expected to be the fastest growing segment.

Detailed Table of Contents:
1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
List Of Tables And Figures
Data Tables
Table 1 Amblyopia Industry Synopsis, 2017 – 2023
Table 2 Global Amblyopia Market Estimates And Forecast, 2017 – 2023, (Usd Million)
Table 3 Global Amblyopia Market By Region, 2017 – 2023, (Usd Million)
Table 4 Global Amblyopia Market By Types, 2017 – 2023, (Usd Million)
Table 5 Global Amblyopia Market By Therapy, 2017 – 2023, (Usd Million)
Table 6 Global Amblyopia Market By End Users, 2017 – 2023, (Usd Million)
Table 7 North America Amblyopia Market By Types, 2017 – 2023, (Usd Million)
Table 8 North America Amblyopia Market By Therapy, 2017 – 2023, (Usd Million)
Figures
Figure 1 Research Process
Figure 2 Segmentation For Global Amblyopia Market
Figure 3 Segmentation Market Dynamics For Global Amblyopia Market
Figure 4 Global Amblyopia Market Share, By Type 2016
Figure 5 Global Amblyopia Market Share, By Therapy 2016
Figure 6 Global Amblyopia Market Share, By End Users, 2016
Figure 7 Global Amblyopia Market Share, By Region, 2016

...Continued!


About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

India CRO Market - Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2023


Market Synopsis of India CRO Market:
A Contract Research Organization (CRO) offers outsourced services to support R&D functions for pharmaceutical, biotechnology, and health companies. The CRO’s service ranges from different research and development activities such as drug discovery, pre-clinical (pre-human in-vitro and in-vivo animal research model) and clinical (in-human) testing. Moreover, the contract research organizations have gained importance in the recent years due to the development of biotechnology and pharmaceutical sectors.
The India CRO market restraints are rising concern for security especially data security and patient security in clinical trials, lack of collaboration between universities and industry. Further, the compromises done by some India CROs on ethical and technical standards are the major market threat.
The India CRO Market growth is expected to flourish at a CAGR of 12.0% during the forecast period.
India has rapidly become one of the preferred destinations for clinical trials owing to its large heterogeneous patient pool, rapidly transforming healthcare market, highly educated physicians and cost competitiveness propels the market growth. In addition, increased investment from foreign companies as well as local market players either individually or in collaboration is likely to boost the market growth during the forecast period. Further, emerging research areas such as diagnostic research are expected to fuel the India CRO market.
Segments:
India CRO market has been segmented on the basis of service types which comprises clinical trials, product development, process development, post-marketing surveillance, quality monitoring and others. On the basis of therapeutic application; market is segmented into oncology, cardiovascular, neurology, nephrology and urology, and others. On the basis of end users; market is segmented into pharmaceutical/biopharmaceutical companies, medical devices companies and academic institutes.
Key Players for India CRO Market: 
·         Quintiles IMS Holdings, Inc.
·         Pharmaceutical Product Development
·         Siro Clinpharm
·         GVK Bio
·         Clininvent
·         CliniRX Tangent Research
·         Ecron Acunova
·         Ace Biomed Pvt. Ltd.
·         Actimus Biosciences Pvt. Ltd.
·         Alkem Laboratories Ltd.
·         Actis Biologics Pvt Ltd.
Regional Analysis of India CRO Market:
The healthcare sector of India is divided between differential geographic regions and states. The South India and western India account for a major share of the Indian CRO market. However of late the CRO industry is shifting to the North. The reasons for this shift is the concentration of regulatory authority such as Director Controller General of India (DCGI) office, Indian Council of Medical Research (ICMR), Directorate General of Foreign Trade (DGFT), Department of Biotechnology (DBT) etc. Also the costs are lower in North India and the genetic pool is more diverse.
Browse More Details @ https://www.marketresearchfuture.com/reports/india-cro-market-2927
Detailed Table of Contents:
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
List Of Tables
Table 1 India Cro Market, 2013-2022 (Usd Million)
Table 2 India Cro Market, By Service Type, 2013-2022 (Usd Million)
Table 3 India Cro Market, By Therapeutic Application, 2013-2022 (Usd Million)
Table 4 India Cro Market, By End User, 2013-2022 (Usd Million)
Table 5 India Cro Market, By Region, 2013-2022 (Usd Million)
List Of Figures
Figure 1 Research Process
Figure 2 Porters Five Forces Model
Figure 3 India Cro Market, By Service Type
Figure 4 India Cro Market, By Therapeutic Application
Figure 5 India Cro Market, By End User
Figure 6 India Cro Market, By Region
Figure 7 India Cro Market: Company Share Analysis, 2016 (%)
...Continued

         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

UTI Treatment Market Expected to Grow at High Cagr during Forecast Period 2018 – 2023


Urinary tract infection (UTI treatment) is the infection of the lower or upper urinary tract due to bacteria such as Escherichia coli, Staphylococcus saprophyticus etc. The symptoms of UTI treatment are pain with urination, frequent urination and urination feeling despite having an empty bladder. The market driving factors for UTI treatment are female anatomy, sexual intercourse, diabetes, obesity etc. Due to the complications of female anatomy UTI treatment affects females more than males with the World Health Organization (WHO) estimating that approximately 50 % of women suffer from UTI treatment at some point of time in their lives resulting in more than 1 million hospitalizations per year. It has further been stated that 1% of boys and 3-8% of girls are diagnosed with UTI treatment and the annual cost of UTI treatment infections treatment to be greater than $1 billion.


The Global urinary tract infection (UTI treatment) drugs market is growing due to factors such as rise in hospital borne infections (nosocomial infections), child birth, old age, obesity, growing health awareness especially about women health etc. However the fastest growth has been registered due to rising use of catheters (catheter associated UTI treatment).

The market constraints include growing drug resistance, unmet clinical needs, increasing incidence of chronic diseases resulting in chronic catheter use and low immunity etc. Taking all these factors into consideration, the Global UTI treatment drugs market will approximately reach to $ 9.89 billion in 2023 from $ 8 billion in 2016 growing at a CAGR of 3.6%.

Key players of Global UTI treatment Market
·         Bayer AG
·         Novartis AG
·         Pfizer Inc.
·         F. Hoffmann-La Roche Ltd
·         AstraZeneca
·         Cipla Inc.
·         Dr. Reddy’s Laboratories Ltd.
·         Johnson & Johnson GlaxoSmithKline

Segmentation
The Global UTI treatment Market is segmented on the basis of drug class which comprises of quinolones, aminoglycosides, β-lactam, azoles and others. On the basis of clinical indications this market is segmented into urethritis, cystitis, and pyelonephritis. On the basis of end users the market is segmented into hospitals and self-administered.
Regional analysis
U.S. accounts for the largest market share of the global UTI treatment market followed by Europe. However Europe has a greater hospitalization rate than the U.S. despite the U.S. having a large spending on healthcare. The regulatory changes in the U.S. such as implementation of Affordable Care Act and Hospital Readmissions Reduction Program coupled with Medicare initiative to penalize unnecessary patient readmissions is expected to take a toll on the U.S UTI treatment market. Asia pacific will be the fastest growing market and the growth will be led by China, and India as these nations have huge population and the low cost of UTI treatment drugs. 

Detailed Table of Contents:
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power Of Suppliers
4.1.2 Bargaining Power Of Customer
4.1.3 Intensity Of Competitor’s
4.1.4 Threat Of New Entrants
...Continued

         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com